FFAR2 and type 2 diabetes mellitus: One animal study showed that administering Lactococcus lactis G15 and Q14 enhanced epithelial barrier function, improved glucose tolerance, and decreased lipid levels by activating SCFA-producing bacteria through the G-protein coupled receptor 43 (GPR43) pathway in type 2 diabetes mice [68].